.

Il reparto dedicato a studi e lavori clinici sulle nostre materie prime.

1. Bergavit®

2. Cicero, A.F., Derosa, G., Borghi, C. 2010. Red yeast rice and statin-intolerant patients. Am J Cardiol 105 (10), 1504.

3. Cicero, A.F., Derosa, G., Parini, A., Maffioli, P., D'Addato, S., Reggi, A., Giovannini, M., Borghi, C. 2013.  Nutr Res 33 (8), 622-628.

4. Guarneri, M., Mercado, N., Suhar, C. 2009. Integrative approaches for cardiovascular disease. Nutr Clin Pract 24 (6), 701-708.

1. European Bulletin of Drug Research, 2001 vol.9 (1):207-211.

2. Physicians’ Desk reference (PDR) for Nutritional Supplements. Prima edizione italiana. CEC & Planta Medica, 2003.

3. González Canga A, Fernández Martínez N, Sahagún AM, García Vieitez JJ, Díez Liébana MJ, Calle Pardo AP, Castro Robles LJ, Sierra

Vega M. Glucomannan: properties and therapeutic applications. Nutr Hosp. 2004; 19(1):45-50.

4. Chua M, Baldwin TC, Hocking TJ, Chan K. Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br. J Ethnopharmacol. 2010; 128(2):268-78.

5. Li S, Cui X, Xie X, Ren Y, Zhou P. Detection of konjac glucomannan in seven Amorphophallus Blume species. China Journal of Chinese Materia Medica 1996; 21:456-8.

1. Salminen, Seppo; Lee, Yuan C., Handbook of probiotics and prebiotics, Chichester, John Wiley & Sons, 2009, p. 596, ISBN 0-470-13544-1.

2. Philip D. Marsh BSc PhD, Oral Microbiology, Edinburgh, Churchill Livingstone, 2009, pp. 35, 112, ISBN 0-443-10144-2.

3. Handbook of Fermented Functional Foods, Second Edition (Functional Foods and Nutraceuticals), Washington, DC, Taylor & Francis, 2008, p. 581, ISBN 1-4200-5326-4.

1. Ma XR, Sun ZK, Liu YR, Jia YJ, Zhang BA. Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen Res. 2013;8(22):2050-2059.

2. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells, Francesca De Amicis, Francesca Giordano, Adele Vivacqua, Michele Pellegrino, Maria Luisa Panno, Donatella Tramontano, Suzanne A. W. Fuqua, Sebastiano Andò, FASEB J., ottobre 2011, vol. 25, nº 10, pp. 3695–3707. doi: 10.1096/fj.10-178871

3. Labinskyy N, Csiszar A et alii, Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen Curr Med Chem. 2006;13(9):989-96, PMID 16611080

4. Can J Clin Pharmacol. 2006 Fall;13(3):e262-7. Epub 2006 Nov 3.Safety and efficacy of echinacea (Echinacea angustafolia, e. purpurea and e. pallida) during pregnancy and lactation.

1. Amato C., Angiology, 1994, 45 (6 Pt 2), 531.

2. Burton J.L., Wells M., J. Clin. Pathol., 2002, 55, 401.

3. Carpentier P.H., Mathieu M., J. Mal. Vasc., 1998, 23 (2), 106.

4. Cesarone M.R. et al., Angiology, 2005, 56 (1), 1.

5. Diana G. et al., Clin. Ter., 2000, 151 (5), 341.

6. Focus, Bollettino di Farmacovigilanza, 2005, maggio.

7. Friesenecker B., Intern. J. Microcirculation: Clin. and Exp., 1995.

8. Garner R.C. et al., J. Pharm. Sci., 2002, 91 (1), 32.

9. Kumar R.M. et al., Neurocrit. Care, 2011, 14 (3), 438.

10. Labrid C., International Angiology, 1995, 14, 36.

1. Cheng GG, Cai XH, Zhang BH, Li Y, Gu J, Bao MF, Liu YP, Luo XD. Planta Med. 2014 Feb;80(2-3):223-30. doi: 10.1055/s-0033-1360279. Epub 2014 Jan 22.

2. Andrade-Neto VF, Brandão MG, Stehmann JR, Oliveira LA, Krettli AU. J Ethnopharmacol. 2003 Aug;87(2-3):253-6.

3.Malekinejad H, Ahsan S, Delkhosh-Kasmaie F, Cheraghi H, Rezaei-Golmisheh A, Janbaz-Acyabar H. Iran J Basic Med Sci. 2016 Feb;19(2):221-7.

4. Pajovic B, Radojevic N, Dimitrovski A, Tomovic S, Vukovic M. Aging Male. 2016 Apr 5:1-5. [Epub ahead of print]

5. Rafat N, Monfared AS, Shahidi M, Pourfallah TA. J Med Phys. 2016 Jan-Mar;41(1):52-7. doi: 10.4103/0971-6203.177281

1. Erni, B.; Zanolari, B. (1985). "The mannose-permease of the bacterial phosphotransferase system. Gene cloning and purification of the enzyme IIMan/IIIMan complex of Escherichia coli". The Journal of Biological Chemistry 260 (29)

2. Erni, B.; Zanolari, B.; Graff, P.; Kocher, H. P. (1989). "Mannose permease of Escherichia coli. Domain structure and function of the phosphorylating subunit". The Journal of Biological Chemistry 264 (31): 18733–18741.

3. Huber, F.; Erni, B. (1996). "Membrane topology of the mannose transporter of Escherichia coli K12". European Journal of Biochemistry / FEBS 239 (3): 810–817.

4. Kranjčec, Bojana; Papeš, Dino; Altarac, Silvio (2013). "d-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial". World Journal of Urology 32 (1): 79–84

1. Douglas M. Anderson, A. Elliot Michelle, Mosby’s medical, nursing, & Allied Health Dictionary sesta edizione, New York, Piccin, 2004

2. G Ital Nefrol 2013; 30 (5) – ISSN 1724-5590 – © 2013 Società Italiana di Nefrologia

3. Botez M.I. et al., Ann. Neurology, 1982, 12, 479.

4. Boutron-Ruault M.C. et al., Nutr-Cancer, 1996, 26 (3), 337.

5. Carroll C. et al., Aliment Pharmacol. Ther., 2010, 31 (7), 708.

6. Golnik K.C., Schaible E.R., Neuroophalmol., 1994, 14 (3), 163.

7. Harten P., Z. Rheumatol., 2005, 64 (5), 353.

8. Herbert V., Ann. Intern. Med., 1972, 76, 140.

9. Hernandez-Diaz S. et al., N. Engl. J. Med., 2000, 343, 1608.

10. Hoch A.Z. et al., Clin. J. Sport Med., 2010, 20 (3), 205.

1. Douglas M. Anderson, A. Elliot Michelle, Mosby’s medical, nursing, & Allied Health Dictionary sesta edizione, New York, Piccin, 2004

2. Mills J.L. et al., Am. J. Clin. Nutr., 2003, 77, 1474.

3. MRC Vitamin Study Research Group, Lancet, 1991, 338, 131.

4. Muszkat M. et al., Clin. Ther., 2010, 32 (2), 347.

5. Nilsson K. Et al., Eur. J. Clin. Invest., 1996, 26 (10), 853.

6. Oakley G.P. Jr., N. Engl. J. Med., 1998, 338,1060.

7. Panacharuniti N. et al., Am J Clin. Nutr., 1994, 59 (4), 940.

8. Quinlivan E.P., Gregory J.F. 3rd, Am. J. Clin. Nutr., 2003, 77 (1), 221.

9. Rothenberg S.P. et al., N. Engl. J. Med., 2004, 350, 134.

10. Schnyder G. et al., N. Engl. J. Med., 2001, 345 (22), 1593.

11. Selhub J. et al., N. Engl. J. Med., 1995, 332, 286.

12. Shorvon S.D. et al., Br. Med. J., 1980, 281, 1036.

1. G. Trottier, PJ. Boström; N. Lawrentschuk; NE. Fleshner, Nutraceuticals and prostate cancer prevention: a current review., in Nat Rev Urol, vol. 7, nº 1, Jan 2010, pp. 21-30

2. Plosker GL, Brogden RN, Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia

3. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms a placebo-controlled, double-blind, multicenter trial, in World Journal of Urology, vol. 23, nº 2, 2005, pp. 139–146.

4. Aktas O et al: Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis, J Immunol 2004 Nov 1;173(9):5794-800.

5. Kuriyama S et al: Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1, Am J Clin Nutr.

6. Burckhardt IC, et al: Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia, Am J Respir Crit Care Med 2008 May 15;177(10):1135-41.

7. Venables MC et al: Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans, Am J Clin Nutr.